Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Jara

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Rheumatology|August 1, 1992
Human chorionic gonadotrophin and active ankylosing spondylitisL J Jara, L R Espinoza
The Journal of Rheumatology|February 1, 1989
Hyperviscosity syndrome as the initial manifestation of systemic lupus erythematosusL J Jara, N R Capin, C Lavalle
The Journal of Rheumatology|September 1, 1992
Does prolactin have a role in the pathogenesis of systemic lupus erythematosus?L J Jara, C Lavalle, L R Espinoza
Lupus|January 1, 1997
Elevated serum levels of cyclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patientsL J Jara, C Prasad, L R Espinoza
The Journal of Rheumatology|March 1, 1991
Prolactin in primary fibromyalgia and rheumatoid arthritisL J Jara, C Gómez-Sánchez, L R Espinoza
Clinical and Experimental Rheumatology|March 1, 1996
Transient disappearance of serum antiphospholipid antibodies can also be due to prednisone therapyL H Silveira, L J Jara, L R Espinoza
Lupus|September 24, 2005
The impact of gender on clinical manifestations of primary antiphospholipid syndromeL J Jara, G Medina, O Vera-Lastra, et al.
Lupus|March 26, 2009
Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortalityR O Escárcega, M Garcia-Carrasco, L J Jara, et al.
Comprehensive Therapy|June 1, 1991
Epidemiology, diagnosis, and treatment of polymyalgia rheumaticaL R Espinoza, L H Silveira, P Martinez-Osuna, et al.
Lupus|February 12, 2004
Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patientsG Medina, O Vera-Lastra, L Barile, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|August 1, 1992
Human chorionic gonadotrophin and active ankylosing spondylitisL J Jara, L R Espinoza
The Journal of Rheumatology|February 1, 1989
Hyperviscosity syndrome as the initial manifestation of systemic lupus erythematosusL J Jara, N R Capin, C Lavalle
The Journal of Rheumatology|September 1, 1992
Does prolactin have a role in the pathogenesis of systemic lupus erythematosus?L J Jara, C Lavalle, L R Espinoza
Lupus|January 1, 1997
Elevated serum levels of cyclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patientsL J Jara, C Prasad, L R Espinoza
The Journal of Rheumatology|March 1, 1991
Prolactin in primary fibromyalgia and rheumatoid arthritisL J Jara, C Gómez-Sánchez, L R Espinoza
Clinical and Experimental Rheumatology|March 1, 1996
Transient disappearance of serum antiphospholipid antibodies can also be due to prednisone therapyL H Silveira, L J Jara, L R Espinoza
Lupus|September 24, 2005
The impact of gender on clinical manifestations of primary antiphospholipid syndromeL J Jara, G Medina, O Vera-Lastra, et al.
Lupus|March 26, 2009
Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortalityR O Escárcega, M Garcia-Carrasco, L J Jara, et al.
Comprehensive Therapy|June 1, 1991
Epidemiology, diagnosis, and treatment of polymyalgia rheumaticaL R Espinoza, L H Silveira, P Martinez-Osuna, et al.
Lupus|February 12, 2004
Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patientsG Medina, O Vera-Lastra, L Barile, et al.
Pageof 6